GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fate Therapeutics Inc (STU:F6T) » Definitions » Net Interest Income (for Banks)

Fate Therapeutics (STU:F6T) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Fate Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Fate Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
12278 Scripps Summit Drive, San Diego, CA, USA, 92131
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.